Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 50 of 75 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/31/00
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 09/30/03
End: -
Due: -
OPTIMOX-aflibercept as First-line Therapy in Patients With Unresectable Metastatic Colorectal Cancer
Phase: N/A
Priority: Normal
Start: 05/31/13
End: 06/30/16
Due: 06/30/17
Phase: N/A
Priority: Normal
Start: 04/30/99
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/04/17
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 11/20/14
End: 12/30/23
Due: 12/30/24
Phase: N/A
Priority: Normal
Start: 09/30/99
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/14/19
End: 09/30/24
Due: 09/30/25
Phase: N/A
Priority: Normal
Start: 05/21/21
End: 04/30/28
Due: 04/30/29
Phase: N/A
Priority: Normal
Start: 12/12/13
End: 07/31/17
Due: 07/31/18
Phase: N/A
Priority: Normal
Start: 12/19/16
End: 09/30/25
Due: 09/30/26
Phase: N/A
Priority: Normal
Start: 07/31/03
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 08/31/99
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 09/30/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 08/31/24
End: 03/31/27
Due: 03/31/28
Phase: N/A
Priority: Normal
Start: 10/23/19
End: 10/31/25
Due: 10/31/26
Phase: N/A
Priority: Normal
Start: 11/22/23
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 07/31/99
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 10/31/05
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/18/15
End: 12/07/16
Due: 12/07/17
Phase: N/A
Priority: Normal
Start: 03/31/08
End: 10/31/13
Due: 10/31/14
Phase: N/A
Priority: Normal
Start: 06/29/21
End: 05/31/22
Due: 05/31/23
Phase: N/A
Priority: Normal
Start: 05/31/99
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/23/22
End: 06/01/40
Due: 06/01/41
Phase: N/A
Priority: Normal
Start: 02/07/22
End: 02/13/23
Due: 02/13/24